In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lundbeck & Altana to mutually market CNS drugs in Germany

Executive Summary

H. Lundbeck and Altana subsidiary Promonta have agreed to jointly market both companies' CNS products in Germany. As part of the agreement, Lundbeck is acquiring a 50% equity stake in Promonta.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Equity
    • Marketing (Licensing)
    • Product or Technology Swap

Related Companies